Effect of 3-month therapy with empagliflozin on ambulatory blood pressure and arterial stiffness in patients with type 2 diabetes mellitus

Ann Afr Med. 2021 Apr-Jun;20(2):154-155. doi: 10.4103/aam.aam_19_20.

Authors

Athanasia K Papazafiropoulou¹, Louisa Mpoumi¹, Styliani Papantoniou¹, Maria Rallatou¹, Stavros Antonopoulos¹, Andreas Melidonis²

Affiliations

¹ First Department of Internal Medicine, Diabetes Center, Tzaneio General Hospital of Piraeus, Piraeus, Greece.
² Diabetes and Cardiometabolic Center, Metropolitan Hospital, Piraeus, Greece.

No abstract available

Publication types

Letter

MeSH terms

Aged
Benzhydryl Compounds / therapeutic use*
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Female
Glucosides / therapeutic use*
Humans
Hypoglycemic Agents / therapeutic use
Male
Middle Aged
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Treatment Outcome
Vascular Stiffness / drug effects*

Substances

Benzhydryl Compounds
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
empagliflozin